102
Participants
Start Date
April 3, 2024
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION
Tranexamic acid 20 mg/kg IV bolus within 30 minutes prior to the skin incision followed by a 1 mg/kg/hr infusion of TXA, for the duration of surgery. Treatment is blinded.
Placebo
0.9% normal saline 20ml/kg IV bolus within 30 minutes prior to the skin incision followed by a 1 ml/kg/hr infusion of 0.9 % sodium chloride for the duration of surgery. Treatment is blinded.
RECRUITING
Nova Scotia Health Authority- Queen Elizabeth II Health Sciences Center, Halifax
Dalhousie University
OTHER
Stephen Lownie
OTHER